PeptidePedia The community reference

Contributions of FormularyFrida

User contributions·20 logged edits·page 1 of 1

Contributions by FormularyFrida, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 9,744 edits includes activity predating the current log.

  1. 13:07, 15 Jun 2026 (diff | hist) STEP trial programme 5,534 ±0 add the discontinuation rate for adverse events in both arms
  2. 13:50, 20 May 2026 (diff | hist) Talk:Prior authorisation 748 +80 /* Reauthorisation on response */ reply
  3. 22:44, 4 May 2026 (diff | hist) Retention time 4,104 ±0 m add the equilibration time to the gradient description
  4. 19:52, 9 Feb 2026 (diff | hist) Chinese Peptide Company 15,513 ±0 de-duplicate a repeated sentence
  5. 05:27, 31 Dec 2025 (diff | hist) Lyophilisation 28,679 ±0 British spelling per PP:MOS
  6. 13:23, 18 Dec 2025 (diff | hist) LEADER trial 4,799 ±0 m name the funder in the sentence, per PP:MOS
  7. 10:12, 4 Dec 2025 (diff | hist) Crude peptide 4,775 ±0 clarify that the cake appearance is an indicator, not a specification
  8. 07:29, 7 Nov 2025 (diff | hist) Insulin syringe 4,944 ±0 give the worked example to two significant figures throughout
  9. 21:09, 4 Oct 2025 (diff | hist) Contract development and manufacturing organisation 5,011 ±0 m rm the blanket claim that excursions are harmless
  10. 18:12, 18 Jun 2025 (diff | hist) Solid-phase peptide synthesis 5,359 ±0 m fix a dangling clause
  11. 06:54, 30 May 2025 (diff | hist) Lyophilisation 22,615 +1,070 add the note that lyophilised material tolerates excursions better than solution
  12. 02:07, 22 May 2025 (diff | hist) Body composition assessment 4,416 +32 clarify that the units differ between the two cited papers
  13. 01:07, 20 May 2025 (diff | hist) Multi-dose vial 15,615 +646 consistent en dashes in ranges
  14. 13:12, 16 May 2025 (diff | hist) Sangon Biotech 7,539 +116 expand the product-scope row in the infobox
  15. 05:48, 26 Apr 2025 (diff | hist) Flourishglobal Peptide Biotech 5,526 +159 attribute the capability claim to the organisation's own material
  16. 20:04, 6 Mar 2025 (diff | hist) Electrospray ionisation 3,478 +252 add the peptide-content point: area percent alone cannot give a mass
  17. 16:29, 14 Dec 2024 (diff | hist) Aspiration risk under anaesthesia 2,915 ±0 correct the renal statement — the caution is about volume depletion
  18. 17:42, 6 Aug 2024 (diff | hist) Reverse-phase HPLC 2,305 ±0 m state the column chemistry and the gradient the figure was obtained on
  19. 13:00, 3 Aug 2024 (diff | hist) Medutest 2,091 ±0 state that the sample was not drawn blind, so it represents the vial and not the lot
  20. 22:05, 29 Jul 2024 (diff | hist) Fmoc chemistry 1,950 ±0 m add the excursion tolerance with the study it derives from